SCHEMBL9769926

SCHEMBL9769926

CCOC(=O)CC(O)CC(O)C=CC(=C(c1ccc(F)cc1)c1ccc(F)cc1)n1nnnc1C

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 3/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9769923 1.00 HMGCR (0.77) HMGCR
SCHEMBL9769919 0.89 HMGCR (0.61) HMGCR
SCHEMBL9769922 0.89 HMGCR (0.61) HMGCR
SCHEMBL10437639 0.89 HMGCR (0.82) HMGCR
SCHEMBL10555078 0.89 HMGCR (0.82) HMGCR
SCHEMBL9769949 0.87 HMGCR (0.64) HMGCR
SCHEMBL9769943 0.87 HMGCR (0.64) HMGCR
SCHEMBL9802506 0.84 HMGCR (0.74) HMGCR
SCHEMBL9769786 0.84 HMGCR (0.74) HMGCR
SCHEMBL9726464 0.83 HMGCR (0.77) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5070206-A INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE; ANTICHOLESTEROL, ANTILIPEMIC BRISTOL-MYERS COMPANY (US) 1991-12-03 US disclosed
US-5010205-A Antihypercholesterolemic tetrazol-1-yl intermediates BRISTOL-MYERS COMPANY (US) 1991-04-23 US disclosed
EP-0355820-A1 Antihypercholesterolemic tetrazol-1-yl compounds Bristol-Myers Squibb Company (US) 1990-02-28 EP disclosed
US-4870187-A ANTILIPEMIC, ATHEROSCLEROSIS BRISTOL-MYERS COMPANY (US) 1989-09-26 US disclosed